Third Pole Therapeutics

📍 Waltham, United States👥 83 employees💰 Last funded Feb 2019
Medical Equipment Manufacturing🌐 pole3.com
Website LinkedIn
Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team’s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies. Our first product is being designed to be a simple, convenient, economical, and lightweight device capable of generating nitric oxide from air on-demand and on-site which potentially eliminates the need for large compressed gas cylinders. We believe our novel approach of creating NO on demand has the promise to create new markets by enabling the worldwide use of inhaled NO in settings outside of acute care.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Third Pole Therapeutics?
Third Pole Therapeutics has 2 investors on record on gritt.io.
When did Third Pole Therapeutics last raise funding?
The most recent investment in Third Pole Therapeutics recorded on gritt.io was in February 2019.
What industry is Third Pole Therapeutics in?
Third Pole Therapeutics operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Third Pole Therapeutics based?
Third Pole Therapeutics is headquartered in Waltham, United States.